VBI Vaccines Inc. (VBIV) Reports In-Line Q2 EPS

VBI Vaccines Inc. (NASDAQ: VBIV) reported Q2 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $300 thousand versus the consensus estimate of $704.33 thousand.

For earnings history and earnings-related data on VBI Vaccines Inc. (VBIV) click here.

You May Also Be Interested In

• Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
• Philip Morris (PM) beats Q1 earnings, revenue estimates; issues upbeat guidance
• Lockheed Martin (LMT) Tops Q1 EPS by 59c, Beats on Revenue; Offers FY24 Guidance